SectorBiological Technology
Established Date26/06/1984
Listing Date09/08/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees41
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3050 Post Oak Blvd, Suite 510-T80 Houston, TX 77056
Business
IntroductionAinos, Inc., a Texas corporation, was founded on June 26, 1984. Ainos is a diversified medical technology company focused on the development of novel point-of-care tests (POCT), low-dose interferon therapy and synthetic RNA (SRNA) to drive preventive medicine. Since its inception, the company has focused on research into low-dose non-injectable interferon therapies. The company recently expanded its product candidates to POCT to diversify the company's revenue streams. The POCT device is based on the core technology involved in the COVID 19 POCT product and other POCT products that detect volatile organic compounds (VOCs) released by the human body.
